AP-301

AP-301 · Apeptico Forschung und Entwicklung GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP-301, covering 2019-11-18 to 2019-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung Transplantation [Phase 2]

See pricing